Articles Tagged with
Preliminary research in youth with chronic pain suggests differences in attention and working memory, which has been similarly demonstrated in adults with chronic pain. Read more.
Preliminary research in youth with chronic pain suggests differences in attention and working memory, which has been similarly demonstrated in adults with chronic pain. Read more.
Chronic pain is a condition in the nervous system where a light switch seemingly got turned on and never got turned off. Patients initially experience pain because of some type of injury that has occurred (i.e. a noxious stimuli). This is nature’s way of helping us protect ourselves from further injury. The pain typically stops once the noxious stimuli has discontinued and enough time has passed for the injury to heal itself. Chronic pain occurs when patients continue to experience pain even though the noxious stimuli has stopped and the injury has healed with time. Read more.
Boston-based Massachusetts General Hospital and Fern Health, a provider of digital programs for chronic pain, have expanded their collaboration, giving the company access to 10 million de-identified patient records to help refine and personalize its offerings. Read more.
The long-term goal of this two-phase project is to reduce chronic pain and co-morbid conditions among veterans, through scalable, non-pharmacologic evidence-based strategies that are “veteran-centric,” designed to optimize engagement, adherence and sustainability, and are deliverable to large numbers of veterans. Read more.
A recent study from researchers at CÚRAM, the Science Foundation Ireland Research Centre for Medical Devices at NUI Galway, explores the use of optogenetics as a method to relieve chronic pain. Optogenetics uses genetically-encoded proteins that change position and shape in the presence of light to turn brain cells on or off. Read more.
Chronic low back pain has high societal and personal impact but remains challenging to treat. Electroacupuncture has demonstrated superior analgesia compared with placebo in animal studies but has not been extensively studied in human chronic pain conditions. Read more.
Releviate™ Therapeutics, a bio-pharmaceutical company addressing the needs of patients suffering from chronic pain, signs an exclusive license for two patent pending human monoclonal antibodies developed by researchers at the University of California, Riverside and Duke University. Read more.
AAPM member Paul Glare, MD, discusses the work of the multidisciplinary unit at Pain Management Research Institute (PMRI), University of Sydney, Australia, that focuses on the medical, psychological, and philosophical aspects of pain. Read more.
Chronic pain is a complex neurologic condition that involves both sensory and affective components. A crucial integrator of pain-related sensation and affect may be a set of neurons within the parabrachial nucleus. Read more.
PainQx is conducting a study to collect electroencephalography (EEG) data from 250 people with chronic pain and 50 healthy controls in order to develop algorithms that will objectively assess the level of pain a person is experiencing. Read more.
© American Academy of Pain Medicine. All Rights Reserved.
American Academy of Pain (AAMP) is a nonprofit, 501(c)(3) tax-exempt organization.
1705 Edgewater Drive, #7778
Orlando, FL 32804
Phone: (800) 917-1619 Ext. 102
Fax: (407) 749-0714
American Academy of Pain Medicine
